The report "Medical Elastomers Market by Type (Thermoset and Thermoplastic), Application (Medical Tubes, Catheters, Syringes, Gloves, Medical Bags, and Implants), and Region (North America, Europe, APAC, MEA, and South America) Global Forecast to 2022" The medical elastomers market is projected to reach USD 7.92 Billion by 2022, at a CAGR of 7.5% between 2017 and 2022. The medical elastomers market is projected to grow from USD 5.51 Billion in 2017 to USD 7.92 Billion by 2022, at a CAGR of 7.5% from 2017 to 2022. The growth of the market is attributed to rising demand for medical devices across the globe. Increased awareness among governments to provide high-quality healthcare infrastructure is also expected to drive the market for medical devices. This will, in turn, grow the medical elastomers market across the globe.
Based on application, the medical tubes segment accounted for the largest share of the medical elastomers market in 2017. The growth of this application segment is attributed to the increasing use of medical tubes in the diagnosis and treatment of diseases such as diabetes and cancer. Medical elastomers are increasingly used in the manufacturing of medical tubes owing to their low cost, bio durability, biocompatibility, and easy availability.
BASF SE (Germany), DowDuPont (US), Eastman Chemical Company (US), Royal DSM (Netherlands), Solvay S.A. (Belgium), Trelleborg AB (Sweden), Momentive Performance Materials Inc. (US), Celanese Corporation (US), PolyOne Corporation (US), Teknor Apex (US), and Kuraray Co. Ltd. (Japan) are some of the leading players operating in the medical elastomers market.
